Answers are grounded in this paper and cite their sources.
Demonstrates that 100-micrometer bioresorbable vascular stents preserve radial strength and reduce vessel injury, indicating clinical viability for thin-strut polymeric devices.
The major issue of bioresorbable polymer vascular stents (BRPSs) is their insufficient radial capacity relative to metal stents. As a result, BRPSs are always designed with a larger thickness. However, the thicker struts substantially increase the risk of adverse events. Therefore, the clinical demand for thinner BRPSs is becoming increasingly urgent. In this study, we built on our previous research to develop BRPSs with only 100 μm thickness. Through in vitro experiments and numerical simulations, we evaluated the compression, expansion, vessel dilation processes, and hemodynamics of thinner BRPSs. We also validated the feasibility and benefits by in vivo experiments. The results demonstrated that during compression, expansion, and vessel dilation, the thinner BRPSs maintained sufficient Radial strength (RS) and decreased residual stress and plastic strain. They also mitigated intima damage, the recirculation region, and low wall shear stress distribution induced by stent implantation. In vivo experiments showed that thinner BRPSs effectively alleviated concerns related to thicker BRPSs, such as intimal hyperplasia, inflammatory response, and delayed endothelialization. In conclusion, the thinner BRPSs with 100 μm thickness in this study maintain adequate RS and reduce the risks of thicker stents, thereby exhibiting the potential for clinical application.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: